Andrew H. Wei

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Andrew H. Wei

Dec 5, 2024, 15:08 | Drugs

Tranexamic acid among patients with haematological malignancies and severe thrombocytopenia - The Lancet Haematology

The Lancet Haematology shared on X: "NEW-Tranexamic acid did not prevent bleeding in patients with…

Oct 7, 2024, 09:03 | Blog

Syed Ali Abutalib: How I Treat patients with AML using azacitidine and venetoclax

Syed Ali Abutalib, Assistant Director, Cancer Treatment Centers of America, shared an article on X:…

Aug 18, 2024, 15:03 | Blog

Jorge Cortes: Olutasidenib among patients with R/R AML mIDH1 previously treated with venetoclax

Jorge Cortes, Director of the Georgia Cancer Center, shared on X about recent paper by…

Aug 14, 2024, 07:20 | Drugs

Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax

Keith W Pratz, Director of Leukemia at the Hospital of University of Pennsylvania, shared on…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023